Dapacaro 5 Mg And 10 Mg 5 mg & 10 mg FC tablets
PDF Leaflet Revision Date: 27 January 2026
Clinical Summary
Quick overview from the medicine insert
Indication
Indicated for type 2 diabetes and heart failure.
Dosage (summary)
10 mg once daily for adults; starting dose 10 mg with 500 mg metformin for combination therapy.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Insulin
- Sulfonylureas
- Diuretics
Contraindications
- Type 1 diabetes
- Severe renal impairment
- Pregnancy
- Breastfeeding
- History of pancreatitis
Common side effects
- Hypoglycaemia
- Dizziness
- Urinary tract infections
Counselling Points
- Monitor for signs of ketoacidosis
- Avoid dehydration
- Seek medical attention for genital pain or swelling
Serious warnings
- Risk of ketoacidosis
- Volume depletion
- Necrotising fasciitis
Important Disclaimer
The Dapacaro 5 Mg And 10 Mg 5 mg & 10 mg FC tablets professional information leaflet below is the property of Sandoz Sa Pty Ltd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
